In rare flop, Merck calls it quits on Keytruda-Lynparza combo in prostate cancer aliu Tue, 03/15/2022 – 11:04 More: In rare flop, Merck calls it quits on Keytruda-Lynparza combo in prostate cancer Source: fierce
read moreAfter trial flop, Exelixis drops plan to pair Cabometyx with Roche’s Tecentriq in early-stage liver cancer fkansteiner Tue, 03/15/2022 – 10:16 More: After trial flop, Exelixis drops plan to pair Cabometyx with Roche's Tecentriq in early-stage liver cancer Source: fierce
read moreIndian pharma, US plastic surgeon reach deal to build $50M drug plant in Africa jkeenan Tue, 03/15/2022 – 09:57 More: Indian pharma, US plastic surgeon reach deal to build M drug plant in Africa Source: fierce
read moreProgenity starts oral biologic trial in ulcerative colitis after coming through early clinical test ntaylor Tue, 03/15/2022 – 09:53 More: Progenity starts oral biologic trial in ulcerative colitis after coming through early clinical test Source: fierce
read moreNovo Nordisk adds bioelectronics, biosensors and stimuli-responsive delivery devices to scope of MIT pact ntaylor Tue, 03/15/2022 – 09:30 More: Novo Nordisk adds bioelectronics, biosensors and stimuli-responsive delivery devices to scope of MIT pact Source: fierce
read moreCOVID-19 has highlighted another significant widespread problem – the mental health pandemic More: NHS mental health referrals has reached record high Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals